289 related articles for article (PubMed ID: 11162624)
1. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
Yip-Schneider MT; Lin A; Marshall MS
Biochem Biophys Res Commun; 2001 Feb; 280(4):992-7. PubMed ID: 11162624
[TBL] [Abstract][Full Text] [Related]
2. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
3. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
Yip-Schneider MT; Lin A; Barnard D; Sweeney CJ; Marshall MS
Int J Oncol; 1999 Aug; 15(2):271-9. PubMed ID: 10402237
[TBL] [Abstract][Full Text] [Related]
4. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras.
Warmka JK; Mauro LJ; Wattenberg EV
J Biol Chem; 2004 Aug; 279(32):33085-92. PubMed ID: 15159408
[TBL] [Abstract][Full Text] [Related]
6. ERK regulation upon contact inhibition in fibroblasts.
Wayne J; Sielski J; Rizvi A; Georges K; Hutter D
Mol Cell Biochem; 2006 Jun; 286(1-2):181-9. PubMed ID: 16467968
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
8. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
9. Ecdysone-inducible expression of oncogenic Ha-Ras in NIH 3T3 cells leads to transient nuclear localization of activated extracellular signal-regulated kinase regulated by mitogen-activated protein kinase phosphatase-1.
Plows D; Briassouli P; Owen C; Zoumpourlis V; Garrett MD; Pintzas A
Biochem J; 2002 Mar; 362(Pt 2):305-15. PubMed ID: 11853538
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
12. Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation.
Iida M; Towatari M; Nakao A; Iida H; Kiyoi H; Nakano Y; Tanimoto M; Saito H; Naoe T
Leukemia; 1999 Apr; 13(4):585-9. PubMed ID: 10214865
[TBL] [Abstract][Full Text] [Related]
13. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
[TBL] [Abstract][Full Text] [Related]
14. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
Gopalbhai K; Meloche S
J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
Cagnol S; Rivard N
Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells.
Cook SJ; Beltman J; Cadwallader KA; McMahon M; McCormick F
J Biol Chem; 1997 May; 272(20):13309-19. PubMed ID: 9148952
[TBL] [Abstract][Full Text] [Related]
17. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
18. Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells.
Schliess F; Heinrich S; Häussinger D
Arch Biochem Biophys; 1998 Mar; 351(1):35-40. PubMed ID: 9500841
[TBL] [Abstract][Full Text] [Related]
19. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
Greulich H; Reichman C; Hanafusa H
Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
[TBL] [Abstract][Full Text] [Related]
20. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
Ding XZ; Adrian TE
Biochem Biophys Res Commun; 2001 Mar; 282(2):447-53. PubMed ID: 11401480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]